{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:40:05Z","timestamp":1761975605431,"version":"3.41.0"},"reference-count":89,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2017,5,24]],"date-time":"2017-05-24T00:00:00Z","timestamp":1495584000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Internist"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1007\/s00108-017-0242-z","type":"journal-article","created":{"date-parts":[[2017,5,24]],"date-time":"2017-05-24T12:27:30Z","timestamp":1495628850000},"page":"627-638","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Eisenmangel","Iron deficiency"],"prefix":"10.1007","volume":"58","author":[{"given":"S.","family":"von Haehling","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Ottenjann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. D.","family":"Anker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,5,24]]},"reference":[{"key":"242_CR1","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1002\/ejhf.592","volume":"18","author":"P Ponikowski","year":"2016","unstructured":"Ponikowski P, Voors AA, Anker SD et\u00a0al (2016) 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur J Heart Fail 18:891\u2013975","journal-title":"Eur. J. Heart Fail."},{"issue":"6a","key":"242_CR2","first-page":"399","volume":"60","author":"WY Qunibi","year":"2010","unstructured":"Qunibi WY (2010) The efficacy and safety of current intravenous iron preparations for the management of iron-deficiency anaemia: a\u00a0review. Arzneimittelforschung 60(6a):399\u2013412","journal-title":"Arzneimittelforschung"},{"key":"242_CR3","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1681\/ASN.2006080856","volume":"18","author":"WH Horl","year":"2007","unstructured":"Horl WH (2007) Clinical aspects of iron use in the anemia of kidney disease. J\u00a0Am Soc Nephrol 18:382\u2013393","journal-title":"J Am Soc Nephrol"},{"key":"242_CR4","doi-asserted-by":"crossref","first-page":"62","DOI":"10.4291\/wjgp.v6.i3.62","volume":"6","author":"S Kaitha","year":"2015","unstructured":"Kaitha S, Bashir M, Ali T (2015) Iron deficiency anemia in inflammatory bowel disease. World J Gastrointest Pathophysiol 6:62\u201372","journal-title":"World J Gastrointest Pathophysiol"},{"key":"242_CR5","doi-asserted-by":"crossref","unstructured":"von Haehling S, Jankowska EA, van Veldhuisen DJ et\u00a0al (2015) Iron deficiency and cardiovascular disease. Nat Rev Cardiol 2:659\u2013669","DOI":"10.1038\/nrcardio.2015.109"},{"key":"242_CR6","doi-asserted-by":"crossref","unstructured":"Wurzinger B, K\u00f6nig P (2016) Iron deficiency, fatigue and restless-legs-syndrome. Wien Med Wochenschr 166(13):447\u2013452","DOI":"10.1007\/s10354-016-0497-3"},{"key":"242_CR7","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1136\/gut.2003.035758","volume":"53","author":"C Gasche","year":"2004","unstructured":"Gasche C, Lomer MC, Cavill I, Weiss G (2004) Iron, anaemia, and inflammatory bowel diseases. Gut 53:1190\u20131197","journal-title":"Gut"},{"key":"242_CR8","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.cardfail.2011.08.003","volume":"17","author":"EA Jankowska","year":"2011","unstructured":"Jankowska EA, Rozentryt P, Witkowska A et\u00a0al (2011) Iron deficiency predicts impaired exercise capacity in patients with systolic chronic heart failure. J\u00a0Card Fail 17:899\u2013906","journal-title":"J Card Fail"},{"key":"242_CR9","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.ahj.2013.01.017","volume":"165","author":"IT Klip","year":"2013","unstructured":"Klip IT, Comin-Colet J, Voors AA et al (2013) Iron deficiency in chronic heart failure: an international pooled analysis. Am Heart\u00a0J 165:575\u2013582","journal-title":"Am Heart J"},{"issue":"15","key":"242_CR10","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1016\/j.ejca.2004.06.019","volume":"40","author":"H Ludwig","year":"2004","unstructured":"Ludwig H, Van Belle S, Barrett-Lee P et al (2004) The European Cancer Anaemia Survey (ECAS): a\u00a0large, multinational, prospective survey defining the prevalence, incidence, and treatment of anaemia in cancer patients. Eur J Cancer 40(15):2293\u20132306","journal-title":"Eur J Cancer"},{"issue":"2","key":"242_CR11","first-page":"161","volume":"19","author":"L Gotloib","year":"2006","unstructured":"Gotloib L, Silverberg D, Fudin R et\u00a0al (2006) Iron deficiency is a\u00a0common cause of anemia in chronic kidney disease and can often be corrected with intravenous iron. J\u00a0Nephrol 19(2):161\u2013167","journal-title":"J Nephrol"},{"issue":"3\u20134","key":"242_CR12","first-page":"719","volume":"38","author":"JB Post","year":"2006","unstructured":"Post JB, Wilkes BM, Michelis MF (2006) Iron deficiency in patients with chronic kidney disease: potential role for intravenous iron therapy independent of erythropoietin. Int Urol Nephrol 38(3\u20134):719\u2013723","journal-title":"Int Urol Nephrol"},{"issue":"31","key":"242_CR13","first-page":"49","volume":"47","author":"C Gasche","year":"2000","unstructured":"Gasche C (2000) Complications of inflammatory bowel disease. Hepatogastroenterology 47(31):49\u201356","journal-title":"Hepatogastroenterology"},{"key":"242_CR14","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1016\/S0735-1097(02)01854-5","volume":"39","author":"TB Horwich","year":"2002","unstructured":"Horwich TB, Fonarow GC, Borenstein J et\u00a0al (2002) Anemia is associated with worse symptoms, greater impairment in functional capacity and a\u00a0significant increase in mortality in patients with advanced heart failure. J\u00a0Am Coll Cardiol 39:1780\u20131786","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"242_CR15","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1161\/01.CIR.0000052622.51963.FC","volume":"107","author":"JA Ezekowitz","year":"2003","unstructured":"Ezekowitz JA, McAlister FA, Armstrong PW (2003) Anemia is common in heart failure and is associated with poor outcomes: insights from a\u00a0cohort of 12 065 patients with new-onset heart failure. Circulation 107(2):223\u2013225","journal-title":"Circulation"},{"key":"242_CR16","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1093\/eurheartj\/ehq158","volume":"31","author":"A Jankowska","year":"2010","unstructured":"Jankowska A, Rozentryt P, Witkowska A (2010) Iron deficiency: an ominous sign in patients with systolic chronic heart failure. Eur Heart J 31:1872\u20131880","journal-title":"Eur. Heart J."},{"issue":"2S-2","key":"242_CR17","doi-asserted-by":"crossref","first-page":"568S","DOI":"10.1093\/jn\/131.2.568S","volume":"131","author":"JL Beard","year":"2001","unstructured":"Beard JL (2001) Iron biology in immune function, muscle metabolism and neuronal functioning. J\u00a0Nutr 131(2S-2):568S\u2013580S","journal-title":"J Nutr"},{"issue":"4","key":"242_CR18","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1080\/07315724.2001.10719054","volume":"20","author":"AJ Patterson","year":"2001","unstructured":"Patterson AJ, Brown WJ, Roberts DC (2001) Dietary and supplement treatment of iron deficiency results in improvements in general health and fatigue in Australian women of childbearing age. J\u00a0Am Coll Nutr 20(4):337\u2013342","journal-title":"J Am Coll Nutr"},{"issue":"16","key":"242_CR19","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1002\/mds.22254","volume":"23","author":"C Trenkwalder","year":"2008","unstructured":"Trenkwalder C, Hening WA, Montagna P et al (2008) Treatment of restless legs syndrome: an evidence-based review and implications for clinical practice. Mov Disord 23(16):2267\u20132302","journal-title":"Mov Disord"},{"issue":"1","key":"242_CR20","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.pediatrneurol.2007.08.014","volume":"38","author":"E Konofal","year":"2008","unstructured":"Konofal E, Lecendreux M, Deron J et\u00a0al (2008) Effects of iron supplementation on attention deficit hyperactivity disorder in children. Pediatr Neurol 38(1):20\u201326","journal-title":"Pediatr Neurol"},{"issue":"3","key":"242_CR21","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1093\/ajcn\/85.3.778","volume":"85","author":"LE Murray-Kolb","year":"2007","unstructured":"Murray-Kolb LE, Beard JL (2007) Iron treatment normalizes cognitive functioning in young women. Am J Clin Nutr 85(3):778\u2013787","journal-title":"Am J Clin Nutr"},{"issue":"2","key":"242_CR22","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1055\/s-2008-1027876","volume":"47","author":"JM Stein","year":"2009","unstructured":"Stein JM, Hartmann F, Cordes HJ, Dignass AU (2009) Pathophysiological-based diagnosis and therapy of iron-deficient anaemia in inflammatory bowel disease. Z\u00a0Gastroenterol 47(2):228\u2013236","journal-title":"Z Gastroenterol"},{"issue":"Suppl 2","key":"242_CR23","doi-asserted-by":"crossref","first-page":"676S","DOI":"10.1093\/jn\/131.2.676S","volume":"131","author":"JD Haas","year":"2001","unstructured":"Haas JD, Brownlie T (2001) Iron deficiency and reduced work capacity: a\u00a0critical review to determine a\u00a0causal relationship. J\u00a0Nutr 131(Suppl 2):676S\u2013688S","journal-title":"J Nutr"},{"issue":"9","key":"242_CR24","doi-asserted-by":"crossref","first-page":"354","DOI":"10.20452\/pamw.967","volume":"120","author":"EE Kaldara-Papatheodorou","year":"2010","unstructured":"Kaldara-Papatheodorou EE, Terrovitis JV, Nanas JN (2010) Anemia in heart failure: should we supplement iron in patients with chronic heart failure? Pol Arch Med Wewn 120(9):354\u2013360","journal-title":"Pol Arch Med Wewn"},{"key":"242_CR25","doi-asserted-by":"crossref","unstructured":"Haehling v S, Gremmler U, Krumm M et\u00a0al (2017) Prevalence and\u00a0clinical impact of\u00a0iron deficiency and\u00a0anaemia among\u00a0outpatients with\u00a0chronic heart failure: The PrEP Registry. Clin Res Cardiol 106(6):436\u2013443","DOI":"10.1007\/s00392-016-1073-y"},{"issue":"11","key":"242_CR26","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1093\/eurheartj\/ehs224","volume":"34","author":"EA Jankowska","year":"2013","unstructured":"Jankowska EA, von Haehling S, Anker SD et\u00a0al (2013) Iron deficiency and heart failure: diagnostic dilemmas and therapeutic perspectives. Eur Heart\u00a0J 34(11):816\u2013829","journal-title":"Eur Heart J"},{"key":"242_CR27","volume-title":"Clinical practice guidelines in oncology. Cancer- and chemotherapy induced anemia. Version 2.2012. NCCN.org","author":"National Comprehensive Cancer Network (NCCCN)","year":"2011","unstructured":"National Comprehensive Cancer Network (NCCCN) (2011) Clinical practice guidelines in oncology. Cancer- and chemotherapy induced anemia. Version 2.2012. NCCN.org"},{"issue":"11","key":"242_CR28","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1093\/eurheartj\/ehu385","volume":"36","author":"P Ponikowski","year":"2015","unstructured":"Ponikowski P, van Veldhuisen DJ, Comin-Colet J (2015) Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency. Eur Heart\u00a0J 36(11):657\u2013668","journal-title":"Eur Heart J"},{"key":"242_CR29","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.recesp.2015.08.017","volume":"69","author":"C Enjuanes","year":"2016","unstructured":"Enjuanes C, Bruguera J, Grau M et\u00a0al (2016) Iron status in chronic heart failure: impact on symptoms, functional class and submaximal exercise capacity. Rev Esp Cardiol 69:247\u2013255","journal-title":"Rev Esp Cardiol"},{"key":"242_CR30","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/nrcardio.2011.77","volume":"8","author":"DJ Veldhuisen van","year":"2011","unstructured":"van Veldhuisen DJ, Anker SD, Ponikowski P et\u00a0al (2011) Anemia and iron deficiency in heart failure: mechanisms and therapeutic approaches. Nat Rev Cardiol 8:485\u2013493","journal-title":"Nat Rev Cardiol"},{"issue":"3","key":"242_CR31","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/ejhf.229","volume":"17","author":"P Ponikowski","year":"2015","unstructured":"Ponikowski P, Fillipatos G, Colet JC (2015) The impact of intravenous ferric carboxymaltose on renal function: an analysis of the FAIR-HF study. Eur Heart\u00a0J 17(3):329\u2013339","journal-title":"Eur Heart J"},{"key":"242_CR32","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1093\/eurjhf\/hfs033","volume":"14","author":"JJ McMurray","year":"2012","unstructured":"McMurray JJ, Adamopoulos S, Anker SD (2012) ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 14:803\u2013869","journal-title":"Eur J Heart Fail"},{"key":"242_CR33","first-page":"104","volume":"26","author":"J Stein","year":"2013","unstructured":"Stein J, Dignass AU (2013) Management of iron deficiency anemia in inflammatory bowel disease \u2013 a\u00a0practical approach. Ann Gastroenterol 26:104\u2013113","journal-title":"Ann Gastroenterol"},{"key":"242_CR34","doi-asserted-by":"crossref","first-page":"61","DOI":"10.2147\/CEG.S43493","volume":"6","author":"ND Goldberg","year":"2013","unstructured":"Goldberg ND (2013) Iron deficiency anemia in patients with inflammatory bowel disease. Clin Exp Gastroenterol 6:61\u201370","journal-title":"Clin Exp Gastroenterol"},{"key":"242_CR35","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1093\/ecco-jcc\/jju009","volume":"9","author":"AU Dignass","year":"2015","unstructured":"Dignass AU, Gasche C, Bettenworth D, Birgegard G, Danese S, Gisbert JP et\u00a0al (2015) ECCO Guideline\/European consensus on the diagnosis and management of iron deficiency and anaemia in inflammatory bowel diseases. J\u00a0Crohns Colitis 9:211\u2013222","journal-title":"J Crohns Colitis"},{"key":"242_CR36","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.crohns.2012.07.031","volume":"7","author":"W Reinisch","year":"2013","unstructured":"Reinisch W, Staun M, Bhandari S et\u00a0al (2013) State of the iron: how to diagnose and efficiently treat iron deficiency anemia in inflammatory bowel disease. J\u00a0Crohns Colitis 7:429\u2013440","journal-title":"J Crohns Colitis"},{"key":"242_CR37","first-page":"56","volume":"157","author":"H Link","year":"2015","unstructured":"Link H, Schiefke I, Balck K et\u00a0al (2015) Diagnostic and treatment principles of iron deficiency anaemia. MMW Fortschr Med 157:56\u201359","journal-title":"MMW Fortschr Med"},{"key":"242_CR38","volume-title":"Iron deficiency and iron deficiency anemia","author":"R Huch","year":"2006","unstructured":"Huch R, Schaefer R (2006) Iron deficiency and iron deficiency anemia. Thieme, Stuttgart"},{"issue":"7","key":"242_CR39","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1093\/annonc\/mdt118","volume":"24","author":"H Ludwig","year":"2013","unstructured":"Ludwig H et\u00a0al (2013) Prevalence of iron deficiency across different tumors and its association with poor performance status, disease status and anemia. Ann Oncol 24(7):1886\u20131892","journal-title":"Ann Oncol"},{"issue":"8","key":"242_CR40","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1093\/annonc\/mds112","volume":"23","author":"M Aapro","year":"2012","unstructured":"Aapro M et al (2012) Prevalence and management of cancer-related anaemia, iron deficiency and the specific role of i.\u202fv. iron. Ann Oncol 23(8):1954\u20131962","journal-title":"Ann Oncol"},{"key":"242_CR41","doi-asserted-by":"crossref","first-page":"61","DOI":"10.2147\/CLEP.S89480","volume":"8","author":"H Xu","year":"2016","unstructured":"Xu H et al (2016) Incidence of anemia in patients diagnosed with solid tumors receiving chemotherapy, 2010\u20132013. Clin Epidemiol 8:61\u201371","journal-title":"Clin Epidemiol"},{"key":"242_CR42","unstructured":"Kainer F et al (2012) Symptom-orientiertes Management der Eisenmangelan\u00e4mie bei Schwangeren und gyn\u00e4ko-onkologischen Patientinnen. Aktuelle Standards der Diagnostik und Behandlung. GO! Gyn\u00e4kologischer Onkologischer Newsletter des BNGO e.\u00a0V. Mai:101\u2013109."},{"key":"242_CR43","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1186\/1471-2407-13-340","volume":"13","author":"S Wan","year":"2013","unstructured":"Wan S, Lai Y, Myers RE et al (2013) Post-diagnosis hemoglobin change associates with overall survival of multiple malignancies \u2013 results from a\u00a0werden \u2013 year hospital-based cohort of lung, breast, colorectal, and liver cancers. BMC Cancer 13:340","journal-title":"BMC Cancer"},{"issue":"10","key":"242_CR44","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1681\/ASN.2011111078","volume":"23","author":"JL Babitt","year":"2012","unstructured":"Babitt JL, Lin HY (2012) Mechanisms of Anemia in CKD. J\u00a0Am Soc Nephrol 23(10):1631\u20131634","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"242_CR45","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1515\/jpm.2010.132","volume":"39","author":"C Breymann","year":"2011","unstructured":"Breymann C, Bian XM, Blanco-Capito LR et al (2011) Expert recommendations for the diagnosis and treatment of iron-deficiency anemia during pregnancy and the postpartum period in the Asia-Pacific region. J\u00a0Perinat Med 39(2):113\u2013121","journal-title":"J Perinat Med"},{"key":"242_CR46","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1093\/bja\/aeu098","volume":"113","author":"DM Baron","year":"2014","unstructured":"Baron DM, Hochrieser H, Posch M et al (2014) Preoperative anaemia is associated with poor clinical outcome in non-cardiac surgery patients. Br J Anaesth 113:416\u2013423","journal-title":"Br J Anaesth"},{"key":"242_CR47","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1016\/S0140-6736(11)61381-0","volume":"278","author":"KM Musallam","year":"2011","unstructured":"Musallam KM, Tamim HM, Richards T et al (2011) Preoperative anaemia and postoperative outcomes in non-cardiac surgery: a\u00a0retrospective cohort study. Lancet 278:1396\u20131407","journal-title":"Lancet"},{"key":"242_CR48","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1097\/ALN.0b013e3182054d06","volume":"114","author":"LG Glance","year":"2011","unstructured":"Glance LG, Dick AW, Mukamel DB et\u00a0al (2011) Association between intraoperative blood transfusion and mortality and morbidity in patients undergoing noncardiac surgery. Anesthesiology 114:283\u2013292","journal-title":"Anesthesiology"},{"key":"242_CR49","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1007\/s00104-012-2464-x","volume":"84","author":"C H\u00f6nemann","year":"2013","unstructured":"H\u00f6nemann C, Bierbaum M, Heidler J et\u00a0al (2013) Costs of delivering allogenic blood in hospitals. Chirurg 84:426\u2013432","journal-title":"Chirurg"},{"key":"242_CR50","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.bpa.2013.02.001","volume":"27","author":"A Hofmann","year":"2013","unstructured":"Hofmann A, Ozawa S, Farrugia A et\u00a0al (2013) Economic considerations on transfusion medicine and patient blood management. Best Pract Res Clin Anaesthesiol 27:59\u201368","journal-title":"Best Pract Res Clin Anaesthesiol"},{"key":"242_CR51","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1056\/NEJMoa0908355","volume":"361","author":"SD Anker","year":"2009","unstructured":"Anker SD, Comin Colet J, Filippatos G (2009) Ferric carboxymaltose in patients with heart failure and iron deficiency. N\u00a0Engl J Med 361:2436\u20132448","journal-title":"N Engl J Med"},{"key":"242_CR52","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1093\/ndt\/gfn653","volume":"24","author":"F Locatelli","year":"2009","unstructured":"Locatelli F, Covic A, Eckardt KU, Wiecek A, Vanholder R (2009) Anaemia management in patients with chronic kidney disease: a\u00a0position statement by the Anaemia Working Group of European Renal Best Practice (ERBP). Nephrol Dial Transplant 24:348\u2013354","journal-title":"Nephrol Dial Transplant"},{"issue":"8","key":"242_CR53","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1093\/annonc\/mds112","volume":"23","author":"M Aapro","year":"2012","unstructured":"Aapro M, \u00d6sterborg A, Gasc\u00f3n P et al (2012) Prevalence and management of cancer-related anaemia, iron deficiency and the specific role of i.\u202fv. iron. Ann Oncol 23(8):1954\u20131962","journal-title":"Ann Oncol"},{"key":"242_CR54","volume-title":"National Comprehensive Cancer Network, NCCN clinical practice guidelines in oncology: cancer- and chemotherapy-induced anemia, version 2.2015","author":"GM Rodgers","year":"2015","unstructured":"Rodgers GM et al (2015) National Comprehensive Cancer Network, NCCN clinical practice guidelines in oncology: cancer- and chemotherapy-induced anemia, version 2.2015"},{"key":"242_CR55","volume-title":"NCCN Guideline. Cancer and chemotherapy induced anemia. Version 2.2016","author":"GM Rodgers","year":"2016","unstructured":"Rodgers GM et\u00a0al (2016) NCCN Guideline. Cancer and chemotherapy induced anemia. Version 2.2016 ( www.nccn.org )"},{"key":"242_CR56","first-page":"1431","volume":"52","author":"C Prei\u00df","year":"2014","unstructured":"Prei\u00df C et\u00a0al (2014) Updated German clinical practice guideline on \u201cdiagnosis and treatment of Crohn\u2019s disease\u201d 2014 AWMF registration no.: 021\u2013004Z. Gastroenterol 52:1431\u20131484","journal-title":"Gastroenterol"},{"key":"242_CR57","volume-title":"Chronic kidney disease: managing anaemia. NICE guideline","author":"NICE","year":"2015","unstructured":"NICE (2015) Chronic kidney disease: managing anaemia. NICE guideline. nice.org.uk\/guidance\/ng8 (Erstellt: 3 Jun 2015). Zugegriffen: 16.03.2017"},{"key":"242_CR58","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1053\/j.ajkd.2013.06.008","volume":"62","author":"AS Kliger","year":"2013","unstructured":"Kliger AS, Foley RN, Goldfarb DS, Goldstein SL, Johansen K, Singh A et\u00a0al (2013) KDOQI US commentary on the 2012 KDIGO clinical practice guideline for anemia in CKD. Am J Kidney Dis 62:849\u2013859","journal-title":"Am J Kidney Dis"},{"key":"242_CR59","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1111\/bjh.12311","volume":"161","author":"DW Thomas","year":"2013","unstructured":"Thomas DW, Hinchliffe RF, Briggs C, Macdougall IC, Littlewood T, Cavill I (2013) Guideline for the laboratory diagnosis of functional iron deficiency. Br J Haematol 161:639\u2013648","journal-title":"Br J Haematol"},{"issue":"4","key":"242_CR60","first-page":"C5072","volume":"62","author":"JF Dahlerup","year":"2015","unstructured":"Dahlerup JF, Eivindson M, Jacobsen B et\u00a0al (2015) Diagnosis and treatment of unexplained anemia with iron deficiency without overt bleeding. Dan Med\u00a0J 62(4):C5072","journal-title":"Dan Med J"},{"key":"242_CR61","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1097\/EJA.0b013e32835f4d5b","volume":"30","author":"SA Kozek-Langenecker","year":"2013","unstructured":"Kozek-Langenecker SA, Afshari A, Albaladejo P et al (2013) Management of severe perioperative bleeding: guidelines from the European Society of Anaesthesiology. Eur J Anaesthesiol 30:270\u2013382","journal-title":"Eur J Anaesthesiol"},{"key":"242_CR62","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1055\/s-0029-1185993","volume":"69","author":"RL Bergmann","year":"2009","unstructured":"Bergmann RL et\u00a0al (2009) Arbeitskreis zur Erarbeitung fundierter Empfehlungen f\u00fcr die Prophylaxe und Therapie von Eisenmangel und An\u00e4mie in der Geburtsmedizin. Geburtshilfe Frauenheilkd 69:682\u2013686","journal-title":"Geburtshilfe Frauenheilkd"},{"key":"242_CR63","first-page":"450","volume":"32","author":"HP Lipp","year":"2011","unstructured":"Lipp HP (2011) Peroral und intraven\u00f6s anwendbare Eisenpr\u00e4parate. Krankenhauspharmazie 32:450\u2013459","journal-title":"Krankenhauspharmazie"},{"key":"242_CR64","volume-title":"Eisenmangel und Eisenmangelan\u00e4mie. Leitlinie der Deutschen Gesellschaft f\u00fcr H\u00e4matologie und Onkologie (DGHO)","author":"J Hastka","year":"2011","unstructured":"Hastka J, Heimpel H, Metzgeroth G (2011) Eisenmangel und Eisenmangelan\u00e4mie. Leitlinie der Deutschen Gesellschaft f\u00fcr H\u00e4matologie und Onkologie (DGHO). http:\/\/www.dgho-onkopedia.de\/onkopedia\/leitlinien\/eisenmangel-und-eisenmangelanaemie . Zugegriffen: 16.03.2017"},{"key":"242_CR65","unstructured":"European Medicines Agency. Assessment report for: Iron containing intravenous (IV) medicinal products. Procedure number: EMEA\/H\/A-31\/1322. 2013 EMA\/549569\/2013. http:\/\/www.ema.europa.eu\/ema\/index.jsp?curl=pages\/medicines\/human\/referrals\/Intravenous_iron-containing_medicinal_products\/human_referral_000343.jsp&mid=WC0b01ac05805c516f . Zugegriffen: 16.03.2017"},{"key":"242_CR66","first-page":"64","volume":"9","author":"HP Lipp","year":"2016","unstructured":"Lipp HP (2016) Eisen iv und aut-idem Problematik. Dtsch Apoth Ztg 9:64\u201369","journal-title":"Dtsch Apoth Ztg"},{"key":"242_CR67","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.mayocp.2014.10.007","volume":"90","author":"T Avni","year":"2015","unstructured":"Avni T, Bieber A, Grossman A (2015) The safety of intravenous iron preparations: systematic review and meta-analysis. Mayo Clin Proc 90:12\u201323","journal-title":"Mayo Clin Proc"},{"key":"242_CR68","unstructured":"Anker SD et\u00a0al., ESC-Kongress London 2015; Poster P2796"},{"key":"242_CR69","volume-title":"Effect of ferric carboxymaltose on exercise capacity in patients with iron deficiency and chronic heart failure (EFFECT-HF): a randomized controlled study","author":"DJ Veldhuisen Van","year":"2016","unstructured":"Van Veldhuisen DJ, Ponikowski P, Metra M et al (2016) Effect of ferric carboxymaltose on exercise capacity in patients with iron deficiency and chronic heart failure (EFFECT-HF): a randomized controlled study. American Heart Association 2016 Scientific Sessions, New Orleans, November 16, 2016."},{"key":"242_CR70","volume-title":"Oral Iron Repletion Effects On Oxygen Uptake in Heart Failure (IRONOUT). American Heart Association 2016 Scientific Sessions; November 16, 2016; New Orleans","author":"GD Lewis","year":"2016","unstructured":"Lewis GD (2016) Oral Iron Repletion Effects On Oxygen Uptake in Heart Failure (IRONOUT). American Heart Association 2016 Scientific Sessions; November 16, 2016; New Orleans. https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT02188784 . Zugegriffen: 16.03.2017"},{"key":"242_CR71","doi-asserted-by":"crossref","unstructured":"Jankowska EA, Tkaczyszyn M, Suchocki T et al (2016) Effects of intravenous iron therapy in iron-deficient patients with systolic heart failure: a\u00a0meta-analysis of randomized controlled trials. Eur J Heart Fail 18, 786\u2013795","DOI":"10.1002\/ejhf.473"},{"key":"242_CR72","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ijcard.2016.07.135","volume":"222","author":"T Bekfani","year":"2016","unstructured":"Bekfani T, Pelicori P, Morris DA et\u00a0al (2016) Sarcopenia in patients with heart failure with preserved ejection fraction: Impact on muscle strength, exercise capacity and quality of life. Int J Cardiol 222:41\u201346","journal-title":"Int J Cardiol"},{"key":"242_CR73","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.crohns.2012.09.005","volume":"7","author":"G Assche Van","year":"2013","unstructured":"Van Assche G, Dignass A, Bokemeyer B et al (2013) Second European evidence-based consensus on the iagnosis and management of ulcerative colitis: Special situations. J\u00a0Crohns Colitis 7:1\u201333","journal-title":"J Crohns Colitis"},{"key":"242_CR74","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1007\/s40265-013-0131-2","volume":"73","author":"F Gomoll\u00f3n","year":"2013","unstructured":"Gomoll\u00f3n F, Gisbert JP (2013) Current management of iron deficiency anemia in inflammatory bowel diseases: a\u00a0practical guide. Drugs 73:1761\u20131710","journal-title":"Drugs"},{"key":"242_CR75","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1053\/j.gastro.2011.06.005","volume":"141","author":"R Evstatiev","year":"2011","unstructured":"Evstatiev R, Marteau P, Iqbal T et\u00a0al (2011) FERGIcor, a\u00a0randomized controlled trial on ferric carboxymaltose for iron deficiency anemia in inflammatory bowel disease. Gastroenterology 141:846\u2013853","journal-title":"Gastroenterology"},{"key":"242_CR76","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.cgh.2012.10.013","volume":"11","author":"R Evstatiev","year":"2013","unstructured":"Evstatiev R, Alexeeva O, Bokemeyer B et\u00a0al (2013) Ferric carboxymaltose prevents recurrence of anemia in patients with inflammatory bowel disease. Clin Gastroenterol Hepatol 11:269\u2013277","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5","key":"242_CR77","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1097\/MIB.0000000000000648","volume":"22","author":"N Murawska","year":"2016","unstructured":"Murawska N, Fabisiak A, Fichna J (2016) Anemia of chronic disease and iron deficiency anemia in inflammatory bowel diseases: pathophysiology, diagnosis, and treatment. Inflamm Bowel Dis 22(5):1198\u20131208","journal-title":"Inflamm Bowel Dis"},{"key":"242_CR78","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1177\/1756283X15616577","volume":"9","author":"P Koduru","year":"2016","unstructured":"Koduru P, Abraham BP (2016) The role of ferric carboxymaltose in the treatment of iron deficiency anemia in patients with gastrointestinal disease. Therap Adv Gastroenterol 9:76\u201385","journal-title":"Therap Adv Gastroenterol"},{"key":"242_CR79","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1007\/s00508-015-0842-3","volume":"127","author":"H Ludwig","year":"2015","unstructured":"Ludwig H, Evstatiev R, Kornek G et\u00a0al (2015) Iron metabolism and iron supplementation in cancer patients. Wien Klin Wochenschr 127:907\u2013919","journal-title":"Wien Klin Wochenschr"},{"key":"242_CR80","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2016\/8057650","volume":"2016","author":"T Steinmetz","year":"2016","unstructured":"Steinmetz T, Schr\u00f6der J, Plath M et\u00a0al (2016) Antianemic treatment of cancer patients in German routine practice: data from a\u00a0prospective cohort study \u2013 the tumor anemia registry. Anemia 2016:1\u20139","journal-title":"Anemia"},{"key":"242_CR81","unstructured":"Querschnitts-Leitlinien (B\u00c4K) zur Therapie mit Blutkomponenten und Plasmaderivaten. 4. \u00fcberarbeitete und aktualisierte Auflage\u00a02014. http:\/\/www.bundesaerztekammer.de\/fileadmin\/user_upload\/downloads\/QLL_Haemotherapie_2014.pdf . Zugegriffen: 16.03.2017"},{"key":"242_CR82","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1093\/ndt\/gfu201","volume":"29","author":"IC Macdougall","year":"2014","unstructured":"Macdougall IC, Bock AH, Carrera F et al (2014) FIND-CKD: a\u00a0randomized trial of intravenous ferric carboxymaltose versus oral iron in patients with chronic kidney disease and iron deficiency anaemia. Nephrol Dial Transplant 29:2075\u20132084","journal-title":"Nephrol Dial Transplant"},{"key":"242_CR83","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1093\/ndt\/gft251","volume":"29","author":"JE Onken","year":"2014","unstructured":"Onken JE, Bregman DB, Harrington RA et al (2014) Ferric carboxymaltose in patients with iron-deficiency anemia and impaired renal function: the REPAIR-IDA trial. Nephrol Dial Transplant 29:833\u2013842","journal-title":"Nephrol Dial Transplant"},{"key":"242_CR84","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1055\/s-0031-1280743","volume":"46","author":"H Gombotz","year":"2011","unstructured":"Gombotz H, Hofmann A, Rehak P et al (2011) Patient blood management (part 1) \u2013 patient-specific concept to reduce and avoid anemia, blood loss and transfusion. Anasthesiol Intensivmed Notfallmed Schmerzther 46:396\u2013401","journal-title":"Anasthesiol Intensivmed Notfallmed Schmerzther"},{"key":"242_CR85","doi-asserted-by":"crossref","first-page":"6","DOI":"10.2174\/1874321801509010006","volume":"9","author":"S Farmer","year":"2015","unstructured":"Farmer S, Trentino K, Hofmann A et\u00a0al (2015) A programmatic approach to patient blood management \u2013 reducing transfusions and improving patient outcomes. Open Anesthesiol\u00a0J 9:6\u201316","journal-title":"Open Anesthesiol J"},{"key":"242_CR86","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1055\/s-0031-1280743","volume":"46","author":"H Gombotz","year":"2011","unstructured":"Gombotz H, Hofman A, Rehak P et\u00a0al (2011) Patient blood management (part 2). Practice: the 3 pillars. Anasthesiol Intensivmed Notfallmed Schmerzther 46:466\u2013474","journal-title":"Anasthesiol Intensivmed Notfallmed Schmerzther"},{"issue":"1","key":"242_CR87","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/SLA.0000000000001646","volume":"264","author":"B Froessler","year":"2016","unstructured":"Froessler B et\u00a0al (2016) The important role for intravenous iron in perioperative patient blood management in major abdominal surgery. Ann Surg 264(1):41\u201346","journal-title":"Ann Surg"},{"issue":"4","key":"242_CR88","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1053\/j.seminhematol.2015.07.003","volume":"52","author":"C Breymann","year":"2015","unstructured":"Breymann C (2015) Iron deficiency anemia in pregnancy. Semin Hematol 52(4):339\u2013347","journal-title":"Semin. Hematol."},{"key":"242_CR89","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1186\/1471-2407-14-844","volume":"14","author":"Y Zhang","year":"2014","unstructured":"Zhang Y et\u00a0al (2014) Impact of preoperative anemia on relapse and survival in breast cancer patients. BMC Cancer 14:844","journal-title":"BMC Cancer"}],"container-title":["Der Internist"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00108-017-0242-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-017-0242-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-017-0242-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T19:46:36Z","timestamp":1750275996000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00108-017-0242-z"}},"subtitle":["Erkennen und behandeln","Recognition and treatment"],"short-title":[],"issued":{"date-parts":[[2017,5,24]]},"references-count":89,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["242"],"URL":"https:\/\/doi.org\/10.1007\/s00108-017-0242-z","relation":{},"ISSN":["0020-9554","1432-1289"],"issn-type":[{"type":"print","value":"0020-9554"},{"type":"electronic","value":"1432-1289"}],"subject":[],"published":{"date-parts":[[2017,5,24]]}}}